BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250928T013531EDT-0380LxJJZv@132.216.98.100
DTSTAMP:20250928T053531Z
DESCRIPTION:Valentine Laizet\, MSc in Statistics\n\nSenior consultant of HE
 MA\n	Amaris Consulting\n\nNOTE: Meet & Greet Valentine Laizet from 3-3:30pm
  in Room 1140\n\nWHEN: Wednesday\, October 1\, 2025\, from 3:30 to 4:30 p.
 m.\n	WHERE: Hybrid | 2001 91Ö±²¥ College Avenue\, Rm 1140\; Zoom\n	NOTE: Val
 entine Laizet will be presenting in-person at SPGH\n\nAbstract\n\nAmaris C
 onsulting is an international consulting firm operating across multiple ma
 rkets and sectors worldwide. Within our organization\, the Health Economic
 s and Market Access (HEMA) department specializes in delivering strategic 
 consulting services to pharmaceutical companies and other stakeholders in 
 the Health Economics and Outcomes Research (HEOR) space. Our work combines
  in-depth disease knowledge with robust analytical and strategic capabilit
 ies to support clients across the full spectrum of health economics\, outc
 omes research\, value communication\, and market access. The HEMA team int
 egrates expertise from several core practices:\n\n\n	Clinical and pharmaceu
 tical insights\, including systematic literature reviews\, interpretation 
 of clinical data\, and contextual understanding of therapeutic areas and d
 isease landscapes\;\n	Biostatistics\, supporting advanced analyses such as 
 indirect treatment comparisons (including network meta-analyses)\, explora
 tory studies using clinical trial data\, machine learning applications\, p
 redictive modeling\, and the use of real-world evidence beyond traditional
  trial settings\;\n	Health economics\, focusing on economic modeling and co
 st-effectiveness analyses to demonstrate the value of therapies in healthc
 are systems.\n\n\nTogether\, these capabilities enable us to provide evide
 nce-driven solutions that inform pricing\, reimbursement\, and access stra
 tegies for innovative medical products.\n\nSpeaker Bio\n\nValentine holds 
 a Master’s Degree (MSc) in statistics from ENSAI engineering school (Franc
 e) with a major in Biostatistics. Valentine has worked in the consulting s
 pace for 6 years and in HEOR space specifically for 3 years. In her previo
 us experience as a biostatistician consultant for cosmetic industry and he
 re at Amaris\, Valentine has worked as experienced consultant and project 
 manager on a variety of projects and developed experience in:\n\n\n	Real-Wo
 rld Evidence analysis: generate real-world evidence on the use of various 
 pharmaceutical products based on data collected from large health insuranc
 e and claims databases (e.g.\, SNDS\, MarketScan®)\, with management of th
 e administrative procedure for data access request.\n	Individual Patient Da
 ta (IPD) analyses: using data collected from randomized controlled clinica
 l trials\, generate evidence on the efficacy of various pharmaceuticals an
 d cosmetic products using different statistical methods such as frequentis
 ts and bayesian statistics and meta-analyses.\n	Indirect treatment comparis
 ons (ITC): generate indirect evidence on the efficacy of various pharmaceu
 ticals and cosmetic products using IPD and aggregated data\, with the use 
 of different statistical methods (network meta-analyses\, matching-adjuste
 d meta-analyses\, simulated treatment comparison).\n	Scientific writing: co
 ntribute to the redaction of several abstracts and creation of posters for
  conferences.\n\n\nWebsite: https://amaris.com/center-of-excellence/hema/
 \n	LinkedIn: www.linkedin.com/in/valentine-laizet \n
DTSTART:20251001T193000Z
DTEND:20251001T203000Z
SUMMARY:Presentation of the Health Economics and Market Access (HEMA) depar
 tment at Amaris Consulting for consulting in Healthcare Economics and Outc
 omes Research (HEOR)
URL:/spgh/channels/event/presentation-health-economics
 -and-market-access-hema-department-amaris-consulting-consulting-368020
END:VEVENT
END:VCALENDAR